Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MIF-CD74 Signaling Defines a Brain-Specific Immune Vulnerability in Metastasis and Neurologic Disease.

Cancer research·2026
Same author

Fueling Immunotherapy Resistance: SSBP4 Links Tumor Cholesterol Biosynthesis to Immune Evasion.

Cancer immunology research·2026
Same author

The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.

Research square·2026
Same author

Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes.

The Journal of clinical investigation·2026
Same author

Circulating tumor DNA in breast cancer: updates from SABCS 2025.

Journal of hematology & oncology·2026
Same author

Premature termination of early-phase cancer clinical trials: "It's the economy, stupid!"

Journal of the National Cancer Institute·2026

Related Experiment Video

Updated: Nov 8, 2025

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

17.0K

Emerging strategies for treating metastasis.

Mark Esposito1, Shridar Ganesan2,3,4, Yibin Kang5,6,7

  • 1Department of Molecular Biology, Princeton University, Princeton, NJ, USA.

Nature Cancer
|April 26, 2021
PubMed
Summary

Targeting cancer metastasis, the main cause of cancer death, remains challenging. This review covers new insights into tumor pathways and immune strategies for treating metastatic cancer effectively.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.4K

Related Experiment Videos

Last Updated: Nov 8, 2025

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

17.0K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.4K

Area of Science:

  • Oncology
  • Cancer Metastasis Research
  • Immunotherapy

Background:

  • Systemic tumor cell spread (metastasis) is the primary cause of cancer-related mortality.
  • Current therapeutic strategies specifically targeting metastasis are limited.
  • Understanding tumor-intrinsic pathways and immune responses is crucial for developing effective anti-metastatic treatments.

Purpose of the Study:

  • To review recent advances in understanding tumor-intrinsic pathways that drive metastatic colonization and therapeutic resistance.
  • To discuss immune-activating strategies for targeting metastatic cancer.
  • To highlight therapeutically exploitable mechanisms and promising treatment strategies.

Main Methods:

  • Literature review of recent preclinical and clinical studies.
  • Analysis of tumor-intrinsic pathways involved in metastasis.
  • Evaluation of immune-based therapeutic strategies for metastatic disease.

Main Results:

  • Advances in understanding tumor-intrinsic drivers of metastasis and resistance.
  • Identification of promising immune-activating strategies for metastatic disease.
  • Focus on therapeutically exploitable mechanisms and emerging treatment areas.

Conclusions:

  • Targeting tumor-intrinsic pathways and leveraging immune activation are key strategies against cancer metastasis.
  • Promising preclinical and clinical developments offer new hope for treating metastatic disease.
  • Continued research into innovative treatments is essential for overcoming the challenges of cancer spread.